Evidence map›Paper›PMID 33670643›Full record

ArticlePathogens (Basel, Switzerland)2021

Exposure to Quaternary Ammonium Compounds Selects Resistance to Ciprofloxacin in

Alizée Guérin, Arnaud Bridier, Patricia Le Grandois, Yann Sévellec, Federica Palma, Benjamin Félix, Listadapt Study Group, Sophie Roussel, Christophe Soumet

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Benzalkonium Chloride Tolerance AmongPathogens (Basel, Switzerland) · 2026
    Article
  5. Evolved populations ofMicrobial genomics · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Phage-Based Control ofViruses · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Phenotypic and genotypic antimicrobial resistance ofThe Lancet regional health. Europe · 2024
    Article
  16. Article
  17. Adaptation mechanisms ofMicrobiology spectrum · 2023
    Article
  18. Mechanisms ofInternational journal of molecular sciences · 2023
    Article
  19. Review
  20. Characterization and Antibiotic Resistance ofFoods (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Alizée GuérinFougères Laboratory, Antibiotics, Biocides, Residues and Resistance Unit, French Agency for Food, Environmental and Occupational Health (ANSES), 35133 Fougères, France.
Arnaud BridierFougères Laboratory, Antibiotics, Biocides, Residues and Resistance Unit, French Agency for Food, Environmental and Occupational Health (ANSES), 35133 Fougères, France.ORCID 0000-0002-7221-8944
Patricia Le GrandoisFougères Laboratory, Antibiotics, Biocides, Residues and Resistance Unit, French Agency for Food, Environmental and Occupational Health (ANSES), 35133 Fougères, France.
Yann SévellecMaisons-Alfort Laboratory of Food Safety, University Paris-Est, French Agency for Food, Environmental and Occupational Health (ANSES), 94700 Maisons-Alfort, France.ORCID 0000-0002-0794-7083
Federica PalmaMaisons-Alfort Laboratory of Food Safety, University Paris-Est, French Agency for Food, Environmental and Occupational Health (ANSES), 94700 Maisons-Alfort, France.
Benjamin FélixMaisons-Alfort Laboratory of Food Safety, University Paris-Est, French Agency for Food, Environmental and Occupational Health (ANSES), 94700 Maisons-Alfort, France.ORCID 0000-0002-8658-8874
Listadapt Study Group
Sophie RousselMaisons-Alfort Laboratory of Food Safety, University Paris-Est, French Agency for Food, Environmental and Occupational Health (ANSES), 94700 Maisons-Alfort, France.
Christophe SoumetFougères Laboratory, Antibiotics, Biocides, Residues and Resistance Unit, French Agency for Food, Environmental and Occupational Health (ANSES), 35133 Fougères, France.ORCID 0000-0001-5721-8068
Agence Nationale de Sécurité Sanitaire de l’Alimentation, de l’Environnement et du Travail · FR

Funding

One Health European Joint Program ListAdapt" ("Adaptive traits of Listeria monocytogenes to its ecological niches"), European Union's Horizon 2020 research and innovation program Grant Agreement Number: 773830
6 · The paper itself

Abstract

In this contribution, the antimicrobial susceptibility toward 11 antibiotics and four biocides of a panel of 205 Listeria monocytogenes (Lm) strains isolated from different ecological niches (i.e., food, animals and natural environment) was evaluated. The impact of exposure to biocides on the antibiotic susceptibilities of Lm was also investigated. Lm strains isolated from food exhibited overall a lower susceptibility (higher minimal inhibitory concentrations, MIC) for ammonium quaternary compounds (QACs) and peracetic acid (PAC) than strains isolated from animals and natural environments. Conversely, the ecological origins of Lm strains did not significantly affect their susceptibilities towards antibiotics. Interestingly, repeated exposure to QACs recurrently led to a decrease in susceptibility toward ciprofloxacin (CIP), a fluoroquinolone antibiotic, largely used in human medicine. Moreover, these lower levels of susceptibility to CIP remained stable in most Lm strains even after subcultures without biocide selection pressure, suggesting an adaptation involving modifications at the genetic level. Results underlined the ability of Lm to adapt to biocides, especially QACs, and the potential link between this adaptation and the selection of resistance toward critical antibiotics such as ciprofloxacin. These data support a potential role of the extensive use of QACs from "farm to fork" in the selection of biocide and antibiotic resistance in pathogenic bacteria such as Lm.

Indexed as

antimicrobial resistancebacterial adaptationbenzalkonium chloridebiocidesciprofloxacindidecyl dimethylammonium chlorideListeria monocytogenes

Identifiers

PMID33670643
PMCPMC7922960
OpenAlexW3129363906

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.